Anca Roseanu, Dr.
Group: Ligand-Receptor Interactions
Department: Ligand-Receptor InteractionsHead of Department
Biography
Papers
-
. "Hybrid bio-nanoporous peptide loaded-polymer platforms with anticancer and antibacterial activities", Nanoscale Advances, (2024)
doi: 10.1039/D3NA00947E
IF: 4.60AI: 0.86 -
. "Mitigation of Cellular and Bacterial Adhesion on Laser Modified Poly (2 Methacryloyloxyethyl Phosphorylcholine)/Polydimethylsiloxane Surface", Nanomaterials 13(1): 64, (2023)
IF: 5.72AI: 0.70 -
. "New Poly(N-isopropylacrylamide-butylacrylate) Copolymer Biointerfaces and Their Characteristic Influence on Cell Behavior In Vitro", International journal of molecular sciences 23(7), (2022)
IF: 5.92AI: 1.12 -
. "In Vitro Effect of Replicated Porous Polymeric Nano-MicroStructured Biointerfaces Characteristics on Macrophages Behavior", Nanomaterials (Basel, Switzerland) 11(8), (2021)
IF: 5.08 -
. "Bioactive Ibuprofen-Loaded PLGA Coatings for Multifunctional Surface Modification of Medical Devices", Polymers 13(9), (2021)
IF: 4.33AI: 0.90 -
. "Salecan-Clay Based Polymer Nanocomposites for Chemotherapeutic Drug Delivery Systems; Characterization and In Vitro Biocompatibility Studies", Materials (Basel, Switzerland) 13(23), (2020)
IF: 3.62AI: 0.80 -
. "Lactoferrin in Bone Tissue Regeneration", Current medicinal chemistry 12(16), (2019)
IF: 3.89 -
. "Human Mesenchymal Stem Cell Response to Lactoferrin-based Composite Coatings", Materials (Basel, Switzerland) 12(20), (2019)
IF: 2.97AI: 0.80 -
. "Lithium-Doped Biological-Derived Hydroxyapatite Coatings Sustain In Vitro Differentiation of Human Primary Mesenchymal Stem Cells to Osteoblasts", Coatings 12(9), (2019)
IF: 2.35 -
. "Macrophage in vitro Response on Hybrid Coatings Obtained by Matrix Assisted Pulsed Laser Evaporation", Coatings(9), (2019)
IF: 2.35 -
. "In vitro behavior of human mesenchymal stem cells on poly(N-isopropylacrylamide) based biointerfaces obtained by matrix assisted pulsed laser evaporation", Applied Surface Science 440: 712-724, (2018)
IF: 5.16AI: 0.60 -
. "Physical-chemical characterization and biological assessment of simple and lithium-doped biological-derived hydroxyapatite thin films for a new generation of metallic implants", Applied Surface Science 439: 724-735, (2018)
IF: 5.15AI: 0.60 -
. "Biocompatible pure ZnO nanoparticles-3D bacterial cellulose biointerfaces with antibacterial properties", Arabian Journal of Chemistry, (2018)
IF: 2.96 -
. "Physical-chemical characterization and biological assessment of simple and lithium-doped biological-derived hydroxyapatite thin films for a new generation of metallic implants", (Applied Surface Science), (2018)
-
. "Diseases of Civilization - Cancer, Diabetes, Obesity and Acne - the Implication of Milk, IGF-1 and mTORC1", Maedica 13(4): 273-281, (2018)
-
. "Lead-Free Piezoelectric (Ba,Ca)(Zr,Ti)O3 Thin Films for Biocompatible and Flexible Devices", ACS applied materials & interfaces 9(1): 266-278, (2017)
IF: 8.30AI: 1.50 -
. "Lipid Nanostructures Containing Atorvastatin Decrease Lipopolysaccharide-Induced Inflammation in Macrophages", (Journal of Nanoscience and Nanotechnology), (2017)
-
. "Modern Technologies for Creating the Thin-Film Systems and Coatings", : 171-191, (2017)
-
. "Optimization of Recombinant Lipoic Acid Ligase Expression from Bacterial Cells", (Romanian Biotechnological Letters), (2016)
-
. "Recent advances in human viruses imaging studies", Journal of basic microbiology 56(6): 591-607, (2016)
-
. "Multifunctional thin films of lactoferrin for biochemical use deposited by MAPLE technique", Applied Surface Science 255(10): 5491-5495, (2009)
AI: 0.60
Grants
Începând cu data de 16.06.2010, Institutul de Biochimie beneficiază de asistenţă financiară nerambursabilă pentru implementarea proiectului “Întărirea capacităţii administrative”, în baza contractului de finanţare nr. 167/16.06.2010 semnat cu Organismul Intermediar ANCS Bucureşti.
Lactoferrin (Lf), an immunomodulatory glycoprotein was shown to interfere with the life-cycles of many viruses. Our group has rationally designed and characterized the anti-HBV activity of an Lf-derived peptide containing one of the cationic clusters. This project proved the concept that the development of non-toxic, small Lf-derived molecule(s) with a broad-spectrum anti-viral activity may constitute a valuable, cheaper alternative to the current standard of care.